The utility of clinical microbiology data for Antimicrobial Resistance (AMR) surveillance is increasingly recognized, although the availability and quality of these data can vary broadly. Troubleshooting the core technical issues related to the use of routine data at different action levels is fundamental to leverage this rich data source. There has been a surge in…